Patent Assignment
Reel/Frame 055873/0427
Assignment of Assignor's Interest
Recorded: 2021-04-09
Pages: 4
Assignors
GEKKIEVA, MARGARITA
Executed: 2015-10-20
WARBURTON, JAMES
Executed: 2015-10-20
WEICHSELBERGER, ANDREAS
Executed: 2015-10-20
Assignee
NOVARTIS PHARMA AG
POSTFACH, BASEL, 4002, SWITZERLAND
Covered Property
(1)
Methods for Treating Ocular Diseases with Brolucizumab
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 9, 2021
From: SALLSTIG, PETER; SCHMIDT, WERNER
To: ALCON RESEARCH, LTD.
Reel/Frame 055873/0611 →
Assignment of Assignor's Interest
Apr 9, 2021
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 055873/0670 →
Assignment of Assignor's Interest
Apr 9, 2021
From: ALCON RESEARCH, LTD.
To: NOVARTIS AG
Reel/Frame 055873/0773 →
Corrective Assignment to Correct the Typo on Page 1, Paragraph 3, Line 5, Entity Alcon Laboratories Should Be Novartis Pharma Ag Previously Recorded on Reel 55873 Frame 427. Assignor(S) Hereby Confirms the Assignment.
Dec 9, 2025
From: GEKKIEVA, MARGARITA; WARBURTON, JAMES; WEICHSELBERGER, ANDREAS
To: NOVARTIS PHARMA AG
Reel/Frame 073978/0202 →